|
|
Volumn 6, Issue 5, 2001, Pages 441-445
|
|
Evaluating the total costs of chemotherapy-induced toxicity: Results from a pilot study with ovarian cancer patients
|
|
Author keywords
Chemotherapy; Costs; Toxicities
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CAREGIVER;
CONTROLLED STUDY;
DAILY LIFE ACTIVITY;
DEVICE;
DRUG INDUCED DISEASE;
FEMALE;
HEALTH CARE COST;
HOSPITAL COST;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
NEUROTOXICITY;
NEUTROPENIA;
OVARY CANCER;
PILOT STUDY;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAREGIVERS;
COST OF ILLNESS;
DATA COLLECTION;
EMPLOYMENT;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
MIDDLE AGED;
NEUTROPENIA;
OVARIAN NEOPLASMS;
PERIPHERAL NERVOUS SYSTEM DISEASES;
REPRODUCIBILITY OF RESULTS;
THROMBOCYTOPENIA;
|
|
EID: 0034750311
PISSN: 10837159
EISSN: None
Source Type: Journal
DOI: 10.1634/theoncologist.6-5-441 Document Type: Article |
|
Times cited : (90)
|
|
References (15)
|
